1 Department of Surgery, Mount Sinai West, New York, New York
2 Department of Surgery, Brookdale University Hospital Center, Brooklyn, New York
3 Department of Surgery, Mayo Clinic Jacksonville, Jacksonville, Florida
4 Department of Surgery, City of Hope, Duarte, California
5 Department of Surgery, Northwell Health, New York, New York
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in HTML and PDF versions of this article on the journal’s Web site (www.dcrjournal.com).
Funding/Support: None reported.
Financial Disclaimers: None reported.
Study Disclaimers: The method described in this review (pressurized intraperitoneal aerosol chemotherapy, PIPAC), as well as the drugs utilized (cisplatin, doxorubicin, oxaliplatin) in the context of aerosolized intraperitoneal administration, are not currently approved by the US Food and Drug Administration.
Poster presentation at the meeting of the Society of American Gastrointestinal and Endoscopic Surgeons, Baltimore, MD, April 3 to 6, 2019.
Correspondence: Richard L. Whelan, M.D., 130 E 77th St, Department of Surgery, 13th Floor, New York, NY 10075. Email: [email protected]